HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy: Difference between revisions
| [pending revision] | [pending revision] |
| Line 196: | Line 196: | ||
|No established significance | |No established significance | ||
|No (NCCN) | |No (NCCN) | ||
| | | rowspan="6" |Involved in RTK/RAS pathway, and associated primarily with near-haploid B-ALL<ref name=":2" /><ref name=":16" /> | ||
|- | |||
|''FLT3'' | |||
|Mutation | |||
|Oncogene | |||
|Recurrent | |||
|No established significance | |||
|No (NCCN) | |||
|- | |- | ||
|''NRAS'' | |''NRAS'' | ||
| Line 204: | Line 211: | ||
|No established significance | |No established significance | ||
|No (NCCN) | |No (NCCN) | ||
| | |- | ||
|''KRAS'' | |||
|Mutation | |||
|Oncogene | |||
|Rare | |||
|No established significance | |||
|No (NCCN) | |||
|- | |||
|''MAPK1'' | |||
|Mutation | |||
|Oncogene | |||
|Rare | |||
|No established significance | |||
|No (NCCN) | |||
|- | |||
|''PTPN11'' | |||
|Mutation | |||
|Oncoogene | |||
|Rare | |||
|No established significance | |||
|No (NCCN) | |||
|- | |- | ||
|''CDKN2A/B'' | |''CDKN2A/B'' | ||